Login  |   Register   |   Submit Article   |   Contact Us   |   My Frontiers   |   Home

Perspective Article
Epilepsy, E/I balance and GABAA receptor plasticity

Institute of Pharmacology and Toxicology, University of Zurich, Switzerland


GABAA receptors mediate most of the fast inhibitory transmission in the CNS. They form heteromeric complexes assembled from a large family of subunit genes. The existence of multiple GABAA receptor subtypes differing in subunit composition, localization and functional properties underlies their role for fi ne-tuning of neuronal circuits and genesis of network oscillations. The differential regulation of GABAA receptor subtypes represents a major facet of homeostatic synaptic plasticity and contributes to the excitation/inhibition (E/I) balance under physiological conditions and upon pathological challenges. The purpose of this review is to discuss recent fi ndings highlighting the signifi cance of GABAA receptor heterogeneity for the concept of E/I balance and its relevance for epilepsy. Specifi cally, we address the following issues: (1) role for tonic inhibition, mediated by extrasynaptic GABAA receptors, for controlling neuronal excitability; (2) signifi cance of chloride ion transport for maintenance of the E/I balance in adult brain; and (3) molecular mechanisms underlying GABAA receptor regulation (traffi cking, posttranslational modifi cation, gene transcription) that are important for homoeostatic plasticity. Finally, the relevance of these fi ndings is discussed in light of the involvement of GABAA receptors in epileptic disorders, based on recent experimental studies of temporal lobe epilepsy (TLE) and absence seizures and on the identifi cation of mutations in GABAA receptor subunit genes underlying familial forms of epilepsy.

Keywords: Temporal lobe epilepsy, absence epilepsy, homeostatic plasticity, tonic inhibition, synaptic plasticity

Citation: Fritschy J (2008) Epilepsy, E/I balance and GABAA receptor plasticity. Front. Mol. Neurosci. (2008) 1:5. doi:10.3389/neuro.02.005.2008

Received: 25 January 2008; paper pending published: 29 January 2008; accepted: 30 January 2008; published online: 28 March 2008.

Edited by: 
Jochen C. Meier, Max Delbrück Center for Molecular Medicine, Germany

Reviewed by: 
Robert J. Harvey, The School of Pharmacy, UK

Copyright: © 2008 Fritschy. This is an open-access article subject to an exclusive license agreement between the authors and the Frontiers Research Foundation, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are credited.

*Correspondence: Jean-Marc Fritschy, Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, CH – 8057 Zurich, Switzerland. e-mail: fritschy@pharma.uzh.ch
Viewing Options
    Abstract
    Full Text
    PDF
Other articles by authors
     On PubMed

AddThis Social Bookmark Button

Article Analytics

Average Rating: 0/10  (0 votes)
Login to rate this title